IDH1 and glioblastoma: Leveraging the high sensitivity of 18F-DOPA PET imaging for glioblastoma, the selected radiomics features, especially TBRmax, from pre-RT images can effectively stratify the patient cohort with un-methylated MGMT and wild-type IDH1, identifying the patients who may benefit most from DERT.